AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17001147 — intervention group
Group type: COMPARATOR
Intervention: Physician faculty
Number of subjects: 144
Study 17001147 — intervention group
Group type: EXPERIMENTAL
Intervention: SPETA
Number of subjects: 144
Study 15351765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive enhancement therapy
Number of subjects: 121
Study 15351765 — intervention group
Group type: COMPARATOR
Intervention: Enriched supportive therapy
Number of subjects: 121
Study 10756576 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin gauze
Number of subjects: 80
Study 10756576 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane foam
Number of subjects: 80
Study 10756576 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethane film
Number of subjects: 80
Study 10756576 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane film
Number of subjects: 80
Study 10756576 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 9266871 — intervention group
Group type: EXPERIMENTAL
Intervention: Two months of inpatient rehabilitation followed by 4 months of outpatient supervision
Number of subjects: 84
Study 8336989 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamiphylline
Number of subjects: 6
Study 8336989 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 6
Study 8336989 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 6437286 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.29 mg/kg, iv) + Physostigmine
Number of subjects: 6
Study 6437286 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (0.21 mg/kg, iv) + Physostigmine
Number of subjects: 6
Study 6437286 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine alone (3 mg, iv)
Number of subjects: 6
Study 6437286 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 30482720 — intervention group
Group type: COMPARATOR
Intervention: Saline (P0)
Number of subjects: 60
Study 30482720 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 25 (P25)
Number of subjects: 60
Study 30482720 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine 50 (P50)
Number of subjects: 60
Study 29095051 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese patients (BMI ≥ 30 kg/m2)
Number of subjects: 2410
Study 29095051 — intervention group
Group type: EXPERIMENTAL
Intervention: High waist circumference (≥102 cm for men, ≥88 cm for women)
Number of subjects: 2410
Study 29095051 — intervention group
Group type: EXPERIMENTAL
Intervention: Increment of 5 kg/m2 in body mass index
Number of subjects: 2410
Study 29095051 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population (both obese and non-obese)
Number of subjects: 2410
Study 27323608 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiangzhi Xiaoban Tablet (JXT), 0.45 g/tablet, 4 tablets each time, 3 times per day for 8 weeks
Number of subjects: 60
Study 27323608 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin Tablet, 20 mg/tablet, 1 tablet each time, once per evening for 8 weeks
Number of subjects: 60
Study 24497220 — intervention group
Group type: EXPERIMENTAL
Intervention: Brotizolam 0.25 mg/day
Number of subjects: 12
Study 24497220 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg/day
Number of subjects: 12
Study 22515899 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual compaction (MC)
Number of subjects: 48
Study 22515899 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic activation for 1 second (1 sec-UC)
Number of subjects: 48
Study 22515899 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic activation for 5 seconds (5 sec-UC)
Number of subjects: 48
Study 22515899 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic activation for 10 seconds (10 sec-UC)
Number of subjects: 48
Study 20404229 — intervention group
Group type: EXPERIMENTAL
Intervention: e-visit platform
Number of subjects: 151
Study 20404229 — intervention group
Group type: COMPARATOR
Intervention: office visit
Number of subjects: 151
Study 17413465 — intervention group
Group type: EXPERIMENTAL
Intervention: Immobilization of the cervical spine in a rigid collar followed by active mobilization
Number of subjects: 458
Study 17413465 — intervention group
Group type: COMPARATOR
Intervention: Advice to 'act-as-usual'
Number of subjects: 458
Study 17413465 — intervention group
Group type: EXPERIMENTAL
Intervention: Active mobilization program (Mechanical Diagnosis and Therapy)
Number of subjects: 458
Study 16720131 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise group (restrict energy intake by 500 kcal/day)
Number of subjects: 0
Study 16720131 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise group
Number of subjects: 0
Study 16720131 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintain usual dietary intake)
Number of subjects: 0
Study 16720131 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise group and Control group
Number of subjects: 0
Study 14723508 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-frequency algorithm for wheeze detection
Number of subjects: 31
Study 14723508 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchodilator drug (Terbutaline)
Number of subjects: 31
Study 14723508 — intervention group
Group type: COMPARATOR
Intervention: Clinical auscultation
Number of subjects: 31
Study 14723508 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-frequency wheeze parameters
Number of subjects: 31
Study 11028835 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-HT3 receptor antagonists (specifically 2 mg intravenous tropisetron)
Number of subjects: 0
Study 11028835 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological changes (depressive disorders)
Number of subjects: 0
Study 8708247 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-driven injury prevention programme
Number of subjects: 0
Study 8708247 — intervention group
Group type: COMPARATOR
Intervention: Health care professional-led prevention presentation
Number of subjects: 0
Study 8708247 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 1622045 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP) 0.3 microgram/kg infusion over 15 min after cardiopulmonary bypass
Number of subjects: 30
Study 1622045 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion over 15 min after cardiopulmonary bypass
Number of subjects: 30
Study 1622045 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP)
Number of subjects: 30
Study 1622045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 6090539 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acyclovir therapy
Number of subjects: 63
Study 6090539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 31928784 — intervention group
Group type: EXPERIMENTAL
Intervention: Italian version of the SIPAT
Number of subjects: 118
Study 31615480 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT intervention delivered by community health workers (CHWs) with tailored text messages on hydroxyurea adherence.
Number of subjects: 104
Study 31615480 — intervention group
Group type: COMPARATOR
Intervention: Usual clinical care plus education handouts (Control group).
Number of subjects: 104
Study 31615480 — intervention group
Group type: EXPERIMENTAL
Intervention: HABIT intervention
Number of subjects: 104
Study 27839892 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacist's intervention (education provided to patients and caregivers)
Number of subjects: 178
Study 25358874 — intervention group
Group type: COMPARATOR
Intervention: Valsartan alone (Group 1)
Number of subjects: 168
Study 25358874 — intervention group
Group type: COMPARATOR
Intervention: Valsartan and Clopidogrel (Group 2)
Number of subjects: 168
Study 25358874 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan and Leflunomide (Group 3)
Number of subjects: 168
Study 25358874 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan, Clopidogrel, and Leflunomide (Group 4)
Number of subjects: 168
Study 23710796 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (10 therapy sessions over 3 months, followed by 4 maintenance sessions over 6 months)
Number of subjects: 480
Study 23710796 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 480
Study 22025630 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime dosing of at least one BP-lowering medication
Number of subjects: 661
Study 19794973 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-duration exercise (treadmill test)
Number of subjects: 100
Study 17707980 — intervention group
Group type: EXPERIMENTAL
Intervention: Butter (B)
Number of subjects: 11
Study 17707980 — intervention group
Group type: EXPERIMENTAL
Intervention: Low TFA margarine (LT)
Number of subjects: 11
Study 17707980 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular margarine (RM)
Number of subjects: 11
Study 17707980 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 11
Study 15339577 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzheng Huayu Capsule (FZHY Capsule)
Number of subjects: 216
Study 15339577 — intervention group
Group type: COMPARATOR
Intervention: Heluo Shugan Capsule (Control)
Number of subjects: 216
Study 10898841 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported overdentures on a transmandibular implant system (n = 21)
Number of subjects: 55
Study 10898841 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-mucosa-supported overdentures on 2 IMZ implants (n = 20)
Number of subjects: 55
Study 10898841 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete dentures (n = 14)
Number of subjects: 55
Study 9151586 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioceram sapphire implants with overdentures
Number of subjects: 86
Study 1358044 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 1 mg/day for 48 hours
Number of subjects: 12
Study 1358044 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 2.5 mg/day for 72 hours
Number of subjects: 12
Study 1358044 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol 2.5 mg for one week then 5 mg for 5 weeks
Number of subjects: 12
Study 1358044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1358044 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 12
Study 6382887 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine treatment
Number of subjects: 33
Study 6382887 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 33
Study 30502314 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants of women with HDP
Number of subjects: 221
Study 30502314 — intervention group
Group type: COMPARATOR
Intervention: Control group (infants of women without HDP)
Number of subjects: 221
Study 29920323 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 g high molecular weight oat β-glucan
Number of subjects: 33
Study 29920323 — intervention group
Group type: COMPARATOR
Intervention: Control breakfast
Number of subjects: 33
Study 28040073 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar locking plate fixation
Number of subjects: 28
Study 28040073 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 28
Study 28040073 — intervention group
Group type: COMPARATOR
Intervention: Control group (Volar locking plate fixation)
Number of subjects: 28
Study 28040073 — intervention group
Group type: COMPARATOR
Intervention: Control group (Intramedullary nailing)
Number of subjects: 28
Study 23852152 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose atorvastatin (80 mg) associated with double-dose clopidogrel (150 mg)
Number of subjects: 76
Study 23852152 — intervention group
Group type: COMPARATOR
Intervention: Double-dose clopidogrel alone
Number of subjects: 76
Study 21048432 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed model for cholesterol-reducing treatments
Number of subjects: 0
Study 21048432 — intervention group
Group type: COMPARATOR
Intervention: General linear model for cholesterol-reducing treatments
Number of subjects: 0
Study 21048432 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed model for sleeplessness treatments
Number of subjects: 0
Study 21048432 — intervention group
Group type: COMPARATOR
Intervention: General linear model for sleeplessness treatments
Number of subjects: 0
Study 20179692 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback therapy (manometric‐assisted pelvic relaxation and simulated defecation training)
Number of subjects: 26
Study 20179692 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback therapy
Number of subjects: 26
Study 20179692 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (diet, exercise, laxatives)
Number of subjects: 26
Study 17328907 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory information with accurate description and real props
Number of subjects: 6
Study 17328907 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory information with accurate description and toy props
Number of subjects: 6
Study 17328907 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory information with accurate description and verbal props
Number of subjects: 6
Study 17328907 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory information with misleading verbal and misleading props
Number of subjects: 6
Study 17328907 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparatory information with accurate description and misleading props
Number of subjects: 6
Study 17328907 — intervention group
Group type: COMPARATOR
Intervention: Attentional control condition
Number of subjects: 6
Study 15766369 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing
Number of subjects: 44
Study 15766369 — intervention group
Group type: COMPARATOR
Intervention: No periodontal treatment (Control)
Number of subjects: 44
Study 11482162 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 gm of ginger powder with fatty meal
Number of subjects: 30
Study 11482162 — intervention group
Group type: COMPARATOR
Intervention: 50 gm of fat
Number of subjects: 30
Study 10193351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapleural streptokinase, 250,000 IU daily for three days
Number of subjects: 24
Study 10193351 — intervention group
Group type: COMPARATOR
Intervention: Control saline flushes for three days
Number of subjects: 24
Study 7915149 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate purity factor VIII or factor IX concentrates, or cryoprecipitate
Number of subjects: 525
Study 7915149 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprecipitate
Number of subjects: 525
Study 3393781 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (oral administration)
Number of subjects: 70
Study 3393781 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (intravenous administration)
Number of subjects: 70
Study 29478257 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib plus dexamethasone (BD)
Number of subjects: 44
Study 29478257 — intervention group
Group type: COMPARATOR
Intervention: Thalidomide plus dexamethasone (TD)
Number of subjects: 44
Study 28139479 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan modified glass ionomer cement (10% v/v)
Number of subjects: 50
Study 28139479 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-cetrimide modified glass ionomer cement (2.5/2.5% w/w)
Number of subjects: 50
Study 28139479 — intervention group
Group type: COMPARATOR
Intervention: Conventional glass ionomer cement
Number of subjects: 50
Study 26444334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection (i.v.) of PHC
Number of subjects: 0
Study 26444334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection (i.m.) of PHC
Number of subjects: 0
Study 24073527 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro‐Relief in‐office desensitizing fluoride‐free paste containing 8% arginine and calcium carbonate (Test Paste group)
Number of subjects: 50
Study 24073527 — intervention group
Group type: COMPARATOR
Intervention: Fluoride‐free prophylaxis paste (Control Paste group)
Number of subjects: 50
Study 21820860 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0mg fluoride tablet (Group A)
Number of subjects: 0
Study 21820860 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5mg fluoride tablet (Group B)
Number of subjects: 0
Study 21820860 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 0
Study 18927594 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspheric IOL (Tecnis ZA9003)
Number of subjects: 48
Study 18927594 — intervention group
Group type: COMPARATOR
Intervention: Spherical IOL (AcrySof SA60AT)
Number of subjects: 48
Study 16620590 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular revaccination (10 microg per dose)
Number of subjects: 40
Study 16620590 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal revaccination (2 microg per dose)
Number of subjects: 40
Study 16620590 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster dose (5 microg) after negative conversion of anti-HBs
Number of subjects: 40
Study 16620590 — intervention group
Group type: COMPARATOR
Intervention: Control group (responder children)
Number of subjects: 40
Study 16620590 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal revaccinees
Number of subjects: 40
Study 16620590 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular revaccinees
Number of subjects: 40
Study 14513920 — intervention group
Group type: EXPERIMENTAL
Intervention: clonidine/caffeine
Number of subjects: 24
Study 14513920 — intervention group
Group type: COMPARATOR
Intervention: clonidine/placebo
Number of subjects: 24
Study 14513920 — intervention group
Group type: EXPERIMENTAL
Intervention: placebo/caffeine
Number of subjects: 24
Study 14513920 — intervention group
Group type: COMPARATOR
Intervention: placebo/placebo
Number of subjects: 24
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Family psychosocial intervention at diagnosis
Number of subjects: 36
Study 11195237 — intervention group
Group type: COMPARATOR
Intervention: Control group treated initially in a hospital ward
Number of subjects: 36
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Children living in one-parent families
Number of subjects: 36
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with fathers having a low level of education
Number of subjects: 36
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 36
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-parent family
Number of subjects: 36
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor glycemic control
Number of subjects: 36
Study 11195237 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal dysfunction
Number of subjects: 36
Study 9212136 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg epidural morphine preemptively 60 min before surgery
Number of subjects: 30
Study 9212136 — intervention group
Group type: COMPARATOR
Intervention: 3 mg epidural morphine at the conclusion of surgery
Number of subjects: 30
Study 9212136 — intervention group
Group type: COMPARATOR
Intervention: Epidural placebo at the same time preoperatively
Number of subjects: 30
Study 9212136 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural placebo at the end of surgery
Number of subjects: 30
Study 7678871 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg finasteride daily
Number of subjects: 36
Study 7678871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 3296607 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline (5.6 mg x kg‐1)
Number of subjects: 24
Study 3296607 — intervention group
Group type: COMPARATOR
Intervention: Thiopental (7 mg x kg‐1)
Number of subjects: 24
Study 31531367 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed flap technique (CFT)
Number of subjects: 10
Study 31531367 — intervention group
Group type: COMPARATOR
Intervention: Open flap technique (OFT)
Number of subjects: 10
Study 28134053 — intervention group
Group type: EXPERIMENTAL
Intervention: r-tPA treatment
Number of subjects: 0
Study 26013140 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anaesthetics
Number of subjects: 45
Study 26013140 — intervention group
Group type: COMPARATOR
Intervention: Anaesthetics and lavage (50 mL saline)
Number of subjects: 45
Study 26013140 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Local anaesthetics and Anaesthetics and lavage)
Number of subjects: 45
Study 26013140 — intervention group
Group type: COMPARATOR
Intervention: Local anaesthetics and lavage
Number of subjects: 45
Study 24519100 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of ovarian cancer risk
Number of subjects: 1555
Study 24519100 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of colon cancer risk
Number of subjects: 1555
Study 24519100 — intervention group
Group type: EXPERIMENTAL
Intervention: Overestimation of ovarian cancer risk
Number of subjects: 1555
Study 24519100 — intervention group
Group type: EXPERIMENTAL
Intervention: Underestimation of ovarian cancer risk
Number of subjects: 1555
Study 24519100 — intervention group
Group type: EXPERIMENTAL
Intervention: Overestimation of colon cancer risk
Number of subjects: 1555
Study 21718959 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin 150,000 U twice daily for 3 days
Number of subjects: 176
Study 21718959 — intervention group
Group type: COMPARATOR
Intervention: Saline vehicle
Number of subjects: 176
Study 19065051 — intervention group
Group type: EXPERIMENTAL
Intervention: Titration of inspired oxygen (FiO(2)) alone
Number of subjects: 23
Study 19065051 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment to ventilator pressures with smaller changes to FiO(2)
Number of subjects: 23
Study 17505996 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle modification program (60-hour training over 10 weeks)
Number of subjects: 60
Study 17505996 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 60
Study 14656717 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid infusion (1.26 micromol.kg(‐1).min(‐1) x 6 h, n = 9)
Number of subjects: 24
Study 14656717 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological dose of insulin (1 mU.kg(‐1).min(‐1) euglycemic hyperinsulinemic clamp x 2 h, n = 6)
Number of subjects: 24